Monday, December 23, 2024
HomeTagsBBT-877

BBT-877

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announced it has received notice from the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics